Why is Fermenta Biotech Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 8.52%
- Poor long term growth as Net Sales has grown by an annual rate of 12.04% and Operating profit at 16.91% over the last 5 years
2
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
3
Below par performance in long term as well as near term
- Along with generating -35.50% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Fermenta Biotec. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Fermenta Biotec.
-35.5%
-0.66
53.50%
Sensex
4.81%
0.41
11.83%
Quality key factors
Factor
Value
Sales Growth (5y)
12.04%
EBIT Growth (5y)
16.91%
EBIT to Interest (avg)
2.62
Debt to EBITDA (avg)
6.60
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
0.77
Tax Ratio
14.40%
Dividend Payout Ratio
9.49%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
7.52%
ROE (avg)
8.09%
Valuation Key Factors 
Factor
Value
P/E Ratio
7
Industry P/E
34
Price to Book Value
1.99
EV to EBIT
6.88
EV to EBITDA
5.78
EV to Capital Employed
1.86
EV to Sales
1.49
PEG Ratio
0.01
Dividend Yield
0.94%
ROCE (Latest)
27.05%
ROE (Latest)
28.66%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
Technical Movement
25What is working for the Company
PBT LESS OI(Q)
At Rs 18.65 cr has Grown at 108.61%
DEBT-EQUITY RATIO(HY)
Lowest at 0.29 times
PAT(Q)
At Rs 18.88 cr has Grown at 65.9%
NET SALES(Q)
At Rs 130.22 cr has Grown at 37.03%
-3What is not working for the Company
OPERATING CF(Y)
Lowest at Rs 40.90 Cr
Loading Valuation Snapshot...
Here's what is working for Fermenta Biotec.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 18.65 cr has Grown at 108.61%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 18.88 cr has Grown at 65.9%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Debt-Equity Ratio - Half Yearly
Lowest at 0.29 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Net Sales - Quarterly
At Rs 130.22 cr has Grown at 37.03%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Fermenta Biotec.
Operating Cash Flow - Annually
Lowest at Rs 40.90 Cr and Fallen
each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (Rs Cr)






